List of Tables
Table 1. Global Biomarker Test Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Cancer
Table 3. Key Players of Cardiovascular
Table 4. Key Players of Infectious Diseases
Table 5. Key Players of Central Nervous System
Table 6. Global Biomarker Test Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Biomarker Test Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Biomarker Test Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Biomarker Test Market Share by Region (2020-2025)
Table 10. Global Biomarker Test Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Biomarker Test Market Share by Region (2026-2031)
Table 12. Biomarker Test Market Trends
Table 13. Biomarker Test Market Drivers
Table 14. Biomarker Test Market Challenges
Table 15. Biomarker Test Market Restraints
Table 16. Global Biomarker Test Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Biomarker Test Market Share by Players (2020-2025)
Table 18. Global Top Biomarker Test Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biomarker Test as of 2024)
Table 19. Ranking of Global Top Biomarker Test Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Biomarker Test Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Biomarker Test, Headquarters and Area Served
Table 22. Global Key Players of Biomarker Test, Product and Application
Table 23. Global Key Players of Biomarker Test, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Biomarker Test Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Biomarker Test Revenue Market Share by Type (2020-2025)
Table 27. Global Biomarker Test Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Biomarker Test Revenue Market Share by Type (2026-2031)
Table 29. Global Biomarker Test Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Biomarker Test Revenue Market Share by Application (2020-2025)
Table 31. Global Biomarker Test Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Biomarker Test Revenue Market Share by Application (2026-2031)
Table 33. North America Biomarker Test Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Biomarker Test Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Biomarker Test Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Biomarker Test Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Biomarker Test Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Biomarker Test Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Biomarker Test Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Biomarker Test Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Biomarker Test Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Biomarker Test Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Biomarker Test Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Biomarker Test Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Biomarker Test Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Biomarker Test Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Biomarker Test Market Size by Country (2026-2031) & (US$ Million)
Table 48. F. Hoffmann-La Roche Company Details
Table 49. F. Hoffmann-La Roche Business Overview
Table 50. F. Hoffmann-La Roche Biomarker Test Product
Table 51. F. Hoffmann-La Roche Revenue in Biomarker Test Business (2020-2025) & (US$ Million)
Table 52. F. Hoffmann-La Roche Recent Development
Table 53. Novartis Company Details
Table 54. Novartis Business Overview
Table 55. Novartis Biomarker Test Product
Table 56. Novartis Revenue in Biomarker Test Business (2020-2025) & (US$ Million)
Table 57. Novartis Recent Development
Table 58. PFIZER Company Details
Table 59. PFIZER Business Overview
Table 60. PFIZER Biomarker Test Product
Table 61. PFIZER Revenue in Biomarker Test Business (2020-2025) & (US$ Million)
Table 62. PFIZER Recent Development
Table 63. GlaxoSmithKline Company Details
Table 64. GlaxoSmithKline Business Overview
Table 65. GlaxoSmithKline Biomarker Test Product
Table 66. GlaxoSmithKline Revenue in Biomarker Test Business (2020-2025) & (US$ Million)
Table 67. GlaxoSmithKline Recent Development
Table 68. GE Healthcare Company Details
Table 69. GE Healthcare Business Overview
Table 70. GE Healthcare Biomarker Test Product
Table 71. GE Healthcare Revenue in Biomarker Test Business (2020-2025) & (US$ Million)
Table 72. GE Healthcare Recent Development
Table 73. Medtronics Company Details
Table 74. Medtronics Business Overview
Table 75. Medtronics Biomarker Test Product
Table 76. Medtronics Revenue in Biomarker Test Business (2020-2025) & (US$ Million)
Table 77. Medtronics Recent Development
Table 78. Quest Diagnostics Company Details
Table 79. Quest Diagnostics Business Overview
Table 80. Quest Diagnostics Biomarker Test Product
Table 81. Quest Diagnostics Revenue in Biomarker Test Business (2020-2025) & (US$ Million)
Table 82. Quest Diagnostics Recent Development
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
Table 86. Authors List of This Report
List of Figures
Figure 1. Biomarker Test Picture
Figure 2. Global Biomarker Test Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Biomarker Test Market Share by Type: 2024 VS 2031
Figure 4. Cancer Features
Figure 5. Cardiovascular Features
Figure 6. Infectious Diseases Features
Figure 7. Central Nervous System Features
Figure 8. Global Biomarker Test Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Biomarker Test Market Share by Application: 2024 VS 2031
Figure 10. Pharma & Biotech Companies Case Studies
Figure 11. Diagnostic Tool Companies Case Studies
Figure 12. Healthcare IT/Big Data Companies Case Studies
Figure 13. Clinical Laboratories Case Studies
Figure 14. Biomarker Test Report Years Considered
Figure 15. Global Biomarker Test Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Biomarker Test Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Biomarker Test Market Share by Region: 2024 VS 2031
Figure 18. Global Biomarker Test Market Share by Players in 2024
Figure 19. Global Top Biomarker Test Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biomarker Test as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Biomarker Test Revenue in 2024
Figure 21. North America Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Biomarker Test Market Share by Country (2020-2031)
Figure 23. United States Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Biomarker Test Market Share by Country (2020-2031)
Figure 27. Germany Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Biomarker Test Market Share by Region (2020-2031)
Figure 35. China Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Biomarker Test Market Share by Country (2020-2031)
Figure 43. Mexico Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Biomarker Test Market Share by Country (2020-2031)
Figure 47. Turkey Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. F. Hoffmann-La Roche Revenue Growth Rate in Biomarker Test Business (2020-2025)
Figure 51. Novartis Revenue Growth Rate in Biomarker Test Business (2020-2025)
Figure 52. PFIZER Revenue Growth Rate in Biomarker Test Business (2020-2025)
Figure 53. GlaxoSmithKline Revenue Growth Rate in Biomarker Test Business (2020-2025)
Figure 54. GE Healthcare Revenue Growth Rate in Biomarker Test Business (2020-2025)
Figure 55. Medtronics Revenue Growth Rate in Biomarker Test Business (2020-2025)
Figure 56. Quest Diagnostics Revenue Growth Rate in Biomarker Test Business (2020-2025)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed